{"id":798,"date":"2024-12-12T16:18:51","date_gmt":"2024-12-12T16:18:51","guid":{"rendered":"http:\/\/cetaitdemain.org\/?p=798"},"modified":"2024-12-12T16:18:51","modified_gmt":"2024-12-12T16:18:51","slug":"1998","status":"publish","type":"post","link":"https:\/\/cetaitdemain.org\/?p=798","title":{"rendered":"\ufeff1998"},"content":{"rendered":"

\ufeff1998. in humans and animals. KEYWORDS: conjugate vaccine, enterobactin, salmochelin, lipocalin ABSTRACT Enterobactin (Ent)-mediated high-affinity iron acquisition is critical for Gram-negative bacteria to survive in MG-132 the sponsor. Given the bacteriostatic effect of lipocalin resulting from its potent Ent-binding ability, immune treatment directly focusing on Ent is definitely encouraging for iron-dependent pathogen control. Recently, an Ent conjugate MG-132<\/a> vaccine was reported, but it still offers several significant weaknesses. In this study, we wanted to develop an innovative Ent Rabbit polyclonal to CapG<\/a> conjugate vaccine that can induce a high level of antibodies directed against Ent and to provide solid evidence demonstrating siderophore-binding capacity of Ent-specific antibodies. Using a simple method, we successfully conjugated purified Ent to different service providers, including keyhole limpet hemocyanin (KLH), bovine serum albumin, and CmeC, a vaccine candidate for control. Subcutaneous immunization of rabbits with the KLH-Ent conjugate induced a strong systemic IgG immune response with an up to 16,384-collapse increase in IgG titer directed against whole conjugate and an up to 4,096-collapse increase in the level of specific anti-Ent IgG. To evaluate the ability of Ent-specific IgG to bind to the Ent derivatives present spp. and and under iron-restricted conditions. This study offers significant potential for broader applications to prevent and control numerous Gram-negative infections in humans and animals. KEYWORDS: conjugate vaccine, enterobactin, salmochelin, lipocalin Intro All Gram-negative bacteria have an absolute requirement for iron in order to survive and colonize the sponsor. In animal hosts, however, iron from numerous sources is not normally available to invading bacteria; the concentrations of free iron are well below the levels required for the growth of Gram-negative bacteria (1). To obtain adequate iron for survival and multiplication, Gram-negative bacteria have evolved complex and efficient genetic systems for iron uptake (1). Of these systems, siderophore (iron chelator)-meditated high-affinity iron acquisition is the most efficient, widely prevalent, and highly conserved strategy used by Gram-negative bacteria to scavenge iron in the sponsor (1, 2). Enterobactin (Ent), a catecholate siderophore that has the highest affinity for ferric iron of all natural siderophore compounds, is an archetype for iron acquisition in Gram-negative bacteria (3). In particular, Ent is produced by most users of of the class (4). In addition, the hydrolyzed Ent derivatives (e.g., linear trimer) and the glycosylated Ent derivatives (named salmochelins) can also be produced and utilized for iron uptake by intestinal commensals and pathogens (e.g., and colonization in the gut (6). Not surprisingly, siderophore-mediated iron acquisition, particularly that mediated through Ent, has been a historically important research area in bacterial pathogenesis and has been targeted for developing numerous iron-dependent pathogen control strategies. In past decades, extensive efforts have been placed on development of specific siderophore biosynthesis inhibitors and the vaccines focusing on surface-exposed iron-regulated outer membrane proteins (1, 7). However, these approaches have had only partial success, primarily due to the difficulty of siderophore synthesis and redundancy of systems for utilization of the ferric-siderophore complex in various Gram-negative pathogens. For example, you will find up to five ferric Ent receptors in (FepA, Cir, Fiu, IroN, and Iha) that display different affinities to Ent and its derived products (8,C12). Clearly, such redundancy, together with other issues (e.g., antigenic variance), increases significant difficulties for developing iron-dependent pathogen control by focusing on outer membrane proteins. Rather than focusing on iron acquisition-related large cellular focuses on (e.g., iron-regulated outer membrane proteins), an innovative out-of-the-box strategy focusing on the extracellular Ent siderophore has been inspired by a unique antibacterial function of lipocalins (13,C17) and further supported by a recent study within the evaluation of an MG-132 Ent conjugate vaccine (18). Lipocalins are sponsor acute-phase proteins secreted by neutrophils and epithelial cells during swelling and quick cell growth. In addition to their important and pleiotropic functions in diverse cellular processes in the sponsor, which are unrelated to antibacterial activity, lipocalins have been demonstrated to be involved in the antibacterial iron depletion strategy of the innate immune system (13,C17). Specifically, lipocalins inhibit infections by and additional Gram-negative bacteria by binding Ent with high affinity, therefore functioning as bacteriostatic providers controlling the growth of bacteria in which Ent-mediated iron acquisition takes on an important part in pathogenesis (13,C17). The bacteriostatic function of lipocalins offers provided a strong rationale for developing lipocalin-like Ent-binding protein to inhibit Ent-mediated iron acquisition in Gram-negative bacteria. It is widely accepted that a huge repertoire of different antibodies can be generated in individual human beings or animals. For example, it has been estimated.<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeff1998. in humans and animals. KEYWORDS: conjugate vaccine, enterobactin, salmochelin, lipocalin ABSTRACT Enterobactin (Ent)-mediated high-affinity iron acquisition is critical for Gram-negative bacteria to survive in MG-132 the sponsor. Given the bacteriostatic effect of lipocalin resulting from its potent Ent-binding ability, immune treatment directly focusing on Ent is definitely encouraging for iron-dependent pathogen control. Recently, an …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[],"class_list":["post-798","post","type-post","status-publish","format-standard","hentry","category-pi3k","entry entry-center"],"_links":{"self":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts\/798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=798"}],"version-history":[{"count":1,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts\/798\/revisions"}],"predecessor-version":[{"id":799,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts\/798\/revisions\/799"}],"wp:attachment":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}